Webdisclosure.com

Search

ADC THERAPEUTICS SA EQS-News: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors

Directive transparence : information réglementée

04/01/2019 07:00